Drugs of Abuse Clinical Controls and Calibrators
BIOCHEMICAL DIAGNOSTICS INC STAT-SKREEN 17H, 2X10ML KIT RX
This item has a minimum qty of 2 per supplier requirements.
JANT PHARMACAL CORPORATION Detectabuse Custom Liquid Control Urine Cotinine, 400 ng/ml, 5ml
NC3457131 DETECTABUSE LIQUID CONTROL URI
Maine Molecular Quality Controls Inc eplex BCID-GN Negative
The eplex BCID-GN Negative is intended for use as an external negative quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of gram-negative pathogens: Acinetobacter baumannii, Bacteroides fragilis, Citrobacter, Cronobacter sakazakii, Enterobacter (non-cloacae complex), Enterobacter cloacae complex, Escherichia coli, Fusobacterium necrophorum, Fusobacterium nucleatum, Haemophilus influenzae, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Neisseria meningitidis, Proteus, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella, Serratia, Serratia marcescens, Stenotrophomonas maltophilia; Pan targets: Pan Candida, Pan Gram-Positive; and resistance genes: CTX-M, IMP, KPC, NDM, OXA and VIM on the cobas eplex blood culture identification gram-negative (BCID-GN) panel performed on the cobas eplex system (Roche Diagnostics).
BIOCHEMICAL DIAGNOSTICS INC Stat-Skreen17, Pos & Neg, 2X10Ml Doa Control.
This item has a minimum qty of 2 per supplier requirements.
DRUGS OF ABUSE 17 drug (300ng Opiate Cutoff) Urine Control Postive and Negative 20ml kitbox (1X10ml each level). Includes THC50, COC300, PCP25, OPI300,AMP1000, MAMP1000,BARB300,BZO300, MTD300,PPX300, TCA1000, OXY100, MDMA500, BUP10, EDDP300, FYL25
Cayman Chemical ICBP112 PosItIve CNTRL 120nmol
An activator of the STING pathway induces secretion of IFN-B in human PBMCs (EC50 130 nM) increases serum levels of Ifn-B Il-6 Tnf and Cxcl1 in wild-type but not Sting-/- mice at 2.5 mg/kg inhibits the cytopathic effect of HCoV-229E in infected MRC-5 cells (EC50 3 nM) decreases the level of SARS-CoV-2 RNA in primary human bronchial airway epithelial cells in an air-liquid interface assay decreases tumor volume and increases survival in a CT26 murine colorectal cancer model at 3 mg/kg this compound is expected to exist in one or both tautomeric forms